ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models. [PDF]
Zhang YW +12 more
europepmc +1 more source
Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]
Wang X +11 more
europepmc +1 more source
Identification of novel gene expression programs in thrombin-stimulated hepatic stellate cells. [PDF]
Mac NA +5 more
europepmc +1 more source
Loss of neuraminidase 1 inhibits the activation of hepatic stellate cells through TGF-β/Smad3 signaling. [PDF]
Zhang Y +5 more
europepmc +1 more source
Rubimaillin ameliorates liver fibrosis by triggering the ferroptosis of activated hepatic stellate cells through targeting CPT1A. [PDF]
Zhang D +11 more
europepmc +1 more source
Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells. [PDF]
Han L +11 more
europepmc +1 more source
Hedyotis diffusa Willd suppresses hepatocellular carcinoma tumor-stromal interactions by inactivating cancer-associated hepatic stellate cells. [PDF]
Chen J +8 more
europepmc +1 more source
Transforming growth factor beta reduces proprotein convertase subtilisin/kexin type 9 in the supernatant of hepatic stellate cells. [PDF]
Bundschuh J +4 more
europepmc +1 more source
Proteomic analysis of 7-octenoic acid antifibrotic effects in TGF-β1 activated hepatic stellate cells. [PDF]
Buakaew W +9 more
europepmc +1 more source

